Patents for C12P 21 - Preparation of peptides or proteins (112,499)
02/2008
02/27/2008CN101130799A Method for producing biological energy source substance by using chitin
02/27/2008CN101130073A Protein expression in baculovirus vector expression systems
02/27/2008CN100371455C Process for preparing pepton
02/27/2008CN100371454C Process for preparing peptone
02/26/2008US7335759 Recombinant immunogens for the generation of antivenoms to the venom of scorpions of the genus Centruroides
02/26/2008US7335754 Ehrlichia canis genes and vaccines
02/26/2008US7335750 Hybrid compositions for intracellular targeting
02/26/2008US7335748 RG1 antibodies and uses thereof
02/26/2008US7335747 agent for detecting a cancer, which comprises a monoclonal antibody that specifically binds to a Mina 53 peptide; produced by hybridoma FERM BP-10157
02/26/2008US7335746 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for stimulating release of tumor necrosis factor from blood; for modulating uptake of glucose by adipocyte cells; for release of proteoglycans from cartilage
02/26/2008US7335745 Vectors with DNA encoding pro polypeptides
02/26/2008US7335744 Prostate cancer specific internalizing human antibodies
02/26/2008US7335742 Comprising human immunoglobulin g1 fc region; mediates antibody-dependent cell-mediated cytotoxicity in presence of effector cells more effectively; binds fc gamma receptor iii with better affinity
02/26/2008US7335740 Monoclonal antibody for use in diagnosis, treatment and prevention of cell proliferative, inflammatory, nervous system and immunological disorders
02/26/2008US7335739 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins
02/26/2008US7335736 Compositions and methods for detecting Treponema palidum
02/26/2008US7335733 Tissue cement proteins from Rhipicephalus appendiculatus
02/26/2008US7335732 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
02/26/2008US7335731 PRO4332 polypeptides
02/26/2008US7335730 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders
02/26/2008US7335729 PRO4320 polypeptide
02/26/2008US7335726 antibiotic daptomycin stereoisomeric compounds; expected to be useful to treat not only "natural" pathogens, but also intermediate drug resistant and drug resistant pathogens
02/26/2008US7335724 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis
02/26/2008US7335722 For use in pharmaceuticals, food additivs
02/26/2008US7335641 Method for stimulating hair follicle cell proliferation
02/26/2008US7335636 SPRR1A and axonal regeneration
02/26/2008US7335516 Methods to improve immunogenicity of antigens and specificity of antibodies
02/26/2008US7335506 Trangenic methylobacillus which has enhanced production of lysine and arginine for use in medicine, animal feeds and cosmetics
02/26/2008US7335504 Engineered enzymes and uses thereof
02/26/2008US7335503 Fermentation medium comprising a granular starch hydrolyzing enzyme having glucoamylase activity (GSHE) produced from a culture of Trichoderma reesei
02/26/2008US7335502 Protein comprising an amino acid sequence having a chlorohydrin and hydroxycarboxylic ester asymmetric hydrolase activity; stereoselectivity ; can produce an optically active compound with an industrial scale by using microorganisms with the gene
02/26/2008US7335501 Derived from fungi of the Penicillium genus; vectors and transformed host organisms containing these polynucleotides encoding the phytases
02/26/2008US7335499 tRNA synthetase
02/26/2008US7335498 decompose a glycoside having soyasapogenol B as an aglycone to produce soyasapogenol B; a polynucleotide encoding such a protein; soyasapogenol B can be obtained independently of the saponin content of, for example, a soybean extract; host is filamentous fungus belonging to genus Trichoderma
02/26/2008US7335495 Washing leaves of Porteresia coarctata with sterile sea water, growing fungus on washed leaves; identifying, purification, transferring purified colony; growing culture medial, removing biomass; freeze drying, solvent extraction
02/26/2008US7335492 Process for partitioning of proteins
02/26/2008US7335491 Control and optimization of cell culture conditions is critically important for successful commercial production of proteins and polypeptides; changing the culture from a first set of culture conditions to a second set of culture conditions so that a metabolic shift of the cells is achieved
02/26/2008US7335490 administering genetic engineered erythropoietin produced in host cells expressing EIA protein of an adenovirus, and optionally statins and angiotensin converting enzyme inhibitors; cardiovascular disorders
02/26/2008US7335488 Fluorescent proteins
02/26/2008US7335486 A site specific clostripain cleavage of single and multicopy polypeptides ( glucagon-like peptide)
02/26/2008US7335482 Method using neutral amino acid transporter expressing cell
02/26/2008US7335479 Assays for sensory modulators using a sensory cell specific G-protein alpha subunit
02/26/2008US7335475 nucleotide sequences coding tumor suppressor (PR/SET) polypeptides for diagnosis, prognosis and treatment of cell proliferative disorders; anticarcinogenic agents; tumor suppressor genes
02/26/2008US7335473 Causative agent of the Mystery Swine Disease, vaccine compositions and diagnostic kits
02/26/2008US7335471 Polypeptides derived from RNA polymerases and use thereof
02/26/2008US7335368 BVH-A2 and BVH-A3 antigens of group B Streptococcus
02/26/2008US7335364 Modified Vaccinia Ankara virus variant
02/26/2008US7335351 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
02/26/2008CA2369590C Sodium/proton antiporter gene
02/26/2008CA2353788C Human cervical cancer 1 protooncogene and protein encoded therein
02/26/2008CA2351722C Mast cell-specific signal transducer and cdna thereof
02/26/2008CA2315241C Protein rim2
02/26/2008CA2260366C Recombinant n-proteinase, and the production, methods and uses thereof
02/26/2008CA2078544C Method and compositions for treating injury
02/25/2008CA2586710A1 O-acetyltransferase from neisseria meningitidis, compositions and methods
02/21/2008WO2008021765A2 Compositions and methods for chemical reporter vectors
02/21/2008WO2008020650A1 A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family with attenuated expression of the ydin gene or the ydib gene or combination thereof
02/21/2008WO2008020474A1 Method of producing colistin bulk powder
02/21/2008WO2008020293A2 West nile virus envelope (e) protein antigen and immunoassay
02/21/2008WO2008020260A2 Use of siderophores in prevention of vascular diseases, production of siderophores and qualifying siderophore containing meat-products
02/21/2008WO2007117857A3 Novel dna polymerase from caldicellulosiruptor kristjanssonii
02/21/2008WO2007103523A3 Antioxidant protein, compositions, and methods of use
02/21/2008WO2007103521A3 Preventing norvaline and norleucine misincorporation in recombinant proteins
02/21/2008WO2006053439A9 Hcv f protein and uses thereof
02/21/2008US20080047037 the polypeptides have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or a high-glucose syrup or a mixed syrup, for liquifying a starch-comprising composition
02/21/2008US20080045701 Human Monoclonal Antibody Having Fat-Reducing Effect
02/21/2008US20080045699 Interleukin-1 Related Gene and Protein
02/21/2008US20080045696 DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus
02/21/2008US20080045695 Fusion Protein Suitable to be Expressed High Effectively and the Production Method thereof
02/21/2008US20080045608 Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa
02/21/2008US20080045454 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same
02/21/2008US20080045453 Method of producing biologically active vitamin K dependent proteins by recombinant methods
02/21/2008US20080044907 Modified cry3a toxins and nucleic acid sequences coding therefor
02/21/2008US20080044898 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake
02/21/2008US20080044867 Pufa polyketide synthase systems and uses thereof
02/21/2008US20080044859 Fibroblast Growth Factor Receptor-Like Molecules and Uses Thereof
02/21/2008US20080044858 Using trangenic fungus to produce heterologous proteins; culturing
02/21/2008US20080044857 Methods For Making And Using Mass Tag Standards For Quantitative Proteomics
02/21/2008US20080044856 Thermostable proteins and methods of making and using thereof
02/21/2008US20080044855 System for regulated and enhanced baculovirus mediated transient transgene expression in mammalian cells
02/21/2008US20080044854 Site-specific incorporation of amino acids into molecules
02/21/2008US20080044853 Stably Maintained Multiple Copies of at Least Two Orf in the Same Orientation
02/21/2008US20080044852 Compositions and methods of preparation thereof
02/21/2008US20080044825 Method for Modulating the Evolution of a Polypeptide Encoded by a Nucleic Acid Sequence
02/21/2008US20080044817 Methods for Producing Recombinant Proteins
02/21/2008US20080044501 Fermented soybean products and methods of producing them
02/21/2008US20080044429 Fc.gamma.RIIB-Specific Antibodies and Methods of Use Thereof
02/21/2008US20080044425 Polypeptides having phospholipase a2 activity
02/21/2008US20080044423 Compounds
02/21/2008US20080044422 CNGH0010 Specific Polynucleotides, Polypeptides, Antibodies, Compositions, Methods and Uses
02/21/2008US20080044420 Anti-IL-13 antibodies, compositions, methods and uses
02/21/2008US20080044417 Cancer, autoimmune and inflammatory disease, vaccines; binds to the extracellular domain of native human Fc gamma RIIB with greater affinity than to the extracellular domain of native human Fc gamma RIIA
02/21/2008US20080044415 Hepatocyte growth factor receptor antagonists and uses thereof
02/21/2008US20080044411 Human glp-1 mimetibodies, compositions, methods and uses
02/21/2008US20080044407 Mage-a3/hpv 16 peptide vaccines for head and neck cancer
02/21/2008CA2660513A1 System, method, and device for the expression or repression of proteins
02/20/2008EP1889917A2 Methods and cells for expression of recombinant protein products
02/20/2008EP1889915A1 APO-2 ligand
02/20/2008EP1889909A1 Improvement of disease resistance of plant by introducing transcription factor gene
02/20/2008EP1889908A1 Anti-cd14 antibody-fused protein